Salvia BioElectronics is a neurotechnology company developing an implantable neuromodulation therapy for people with chronic migraine. The company focuses on providing an alternative treatment option for patients who do not respond adequately to pharmacological therapies.

Its system consists of a thin, flexible implant placed under the skin of the head, designed to deliver targeted electrical stimulation to nerves involved in migraine pathology. The device architecture emphasizes minimal invasiveness, patient comfort, and continuous therapy delivery without the need for frequent intervention.

Salvia BioElectronics’ technology is being advanced through clinical development for use in neurology and headache care settings. The company positions its platform as a disease-specific neuromodulation therapy aimed at reducing migraine frequency and severity rather than a general-purpose brain stimulation device.